🇺🇸 Escitalopram 10mg in United States

85 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Product Substitution Issue — 20 reports (23.53%)
  2. Anxiety — 12 reports (14.12%)
  3. Nausea — 12 reports (14.12%)
  4. Drug Ineffective — 8 reports (9.41%)
  5. Depression — 7 reports (8.24%)
  6. Dizziness — 7 reports (8.24%)
  7. Headache — 6 reports (7.06%)
  8. Intentional Overdose — 5 reports (5.88%)
  9. Agitation — 4 reports (4.71%)
  10. Diarrhoea — 4 reports (4.71%)

Source database →

Escitalopram 10mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Escitalopram 10mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Escitalopram 10mg in United States?

Wake Forest University Health Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.